Review



taqman® snp genotyping sequenom® massarray  (Sequenom)

 
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Sequenom taqman® snp genotyping sequenom® massarray
    Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used <t> genotyping </t> technology and prediction model, inferred populations, and related articles.
    Taqman® Snp Genotyping Sequenom® Massarray, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/taqman+snp+genotyping+assay/pmc11843099-32-6-9
    Average 90 stars, based on 1 article reviews
    taqman® snp genotyping sequenom® massarray - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Forensic DNA phenotyping: a review on SNP panels, genotyping techniques, and prediction models"

    Article Title: Forensic DNA phenotyping: a review on SNP panels, genotyping techniques, and prediction models

    Journal: Forensic Sciences Research

    doi: 10.1093/fsr/owae013

    Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used  genotyping  technology and prediction model, inferred populations, and related articles.
    Figure Legend Snippet: Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used genotyping technology and prediction model, inferred populations, and related articles.

    Techniques Used: Sequencing, Multiplex Assay

    Commercial and non-commercial externally visible characteristics (EVC) panels proposed in the literature, including their reference article, number of phenotypic-informative SNPs (PISNPs), first used  genotyping  technology and prediction model, inferred traits, and related articles
    Figure Legend Snippet: Commercial and non-commercial externally visible characteristics (EVC) panels proposed in the literature, including their reference article, number of phenotypic-informative SNPs (PISNPs), first used genotyping technology and prediction model, inferred traits, and related articles

    Techniques Used: Sequencing, Microarray

    Related Articles

    other:

    Article Title: Forensic DNA phenotyping: a review on SNP panels, genotyping techniques, and prediction models
    Article Snippet: [ ] , 74 aSNPs , TaqMan SNP genotyping Sequenom MassARRAY , NB (STRUCTURE) , 10 populations (sub-Saharan AFR and NAF, EUR, SWAS, NAS, SAS, EAS, SEAS, OCE, NAM) , [ ] .

    Article Title: A novel haplotype of low-frequency variants in the aldosterone synthase gene among northern Han Chinese with essential hypertension
    Article Snippet: Genotyping was performed using the TaqMan SNP genotyping assay (Sequenom Company).

    Article Title: Analysis of the association between Fc receptor family gene polymorphisms and ocular Behçet’s disease in Han Chinese
    Article Snippet: Twenty-three SNPs were genotyped using the MassARRAY system (Sequenom), TaqMan SNP Genotyping Assay and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.

    Article Title: <p>Pharmacogene Variation in Thai <em>Plasmodium vivax</em> Relapse Patients Treated with a Combination of Primaquine and Chloroquine</p>
    Article Snippet: Patients and Methods: Fifty-one patients were genotyped for 74 variants in 18 genes by Sequenom MassARRAY® and Taqman® SNP Real-Time PCR.

    Article Title: Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
    Article Snippet: Fifty-one patients were genotyped for 74 variants in 18 genes by Sequenom MassARRAY ® and Taqman ® SNP Real-Time PCR.

    Article Title: Forensic DNA phenotyping: a review on SNP panels, genotyping techniques, and prediction models.
    Article Snippet: Continued AISNPs Genotyping technology Statistical model Inferred BGA Related articles [68] 142 aSNPs Not used NB (Snipper and STRUCTURE) MLR GDA 4 populations (AFR, EUR, EAS, NAM) [199] [67] 93 aSNPs Not used NN 7 populations (AFR, EUR, CSAS, MEA, EAS, NAM, OCE) NA Japaneseplex [244] 60 aSNPs SNaPshotTM + CE NB (Snipper) EAS sub-populations NA SWA AISNP panel [58] 86 aSNPs TaqMan® SNP genotyping NB (STRUCTURE) SWAS and MED sub-populations [240] EUROFORGEN NAME [79] 111 aSNPs Sequenom® MassARRAY® NB (Snipper and STRUCTURE) NAF and MES [185] [167] 48 aSNPs Not used NB (ADMIXTURE) MLR Chinese sub-populations (Uygur, Han, Mongolian) NA Population Informative Multiplex for the Americas (PIMA) [76] 26 aSNPs SNaPshotTM + CE PCA, NB (Snipper) NAM sub-populations [245] Multiple AISNPs panel [65] 7 Y-SNPs, 12 mt-SNPs, 6 aSNPs SNaPshotTM + CE HRM NB (STRUCTURE) 2 populations (ASN and EUR) NA [246] 31 aSNPs, 21 InDels SNaPshotTM + CE NB (Snipper and STRUCTURE) 5 populations (AFR, EAS, MES, EUR, CSAS) NA Pacifiplex [75] 27 aSNPs, 2 X-SNPs SNaPshotTM + CE NB (Snipper and STRUCTURE) OCE sub-populations [187, 188, 236] MAPlex [247, 248] 144 aSNPs, 20 MH NGS NB (Snipper and STRUCTURE) 3 populations (EAS, SAS, NOCE) [249] EUR: European (NEU: North); AFR: African (WAF: West, NAF: North, NEAF: North-east); ASN: Asian (EAS: East, WEAS: West–east, SAS: South, SWAS: South-west, SEAS: South-east, central-south, NAS: North); EURAS: Eurasian; NAM: Native American; AUS: Australian; OCE: Oceanian (NOCE: Near); PAC: Pacific; NES: Near East; MES: Middle East; MED: Mediterranean; NGS: next generation sequencing; MDS: multidimensional scaling; CRT: classification and regression tree; GDA: genetic distance algorithm; NJ: neighbour joining tree; NB: Naive Bayes; ML: Machine learning; MLR: Multinomial linear regression; SVM: support vector machine; CSAS: central-south Asian; MES: middle eastern; NA: not applicable/available.

    Control:

    Article Title: Identification of Loci at 1q21 and 16q23 That Affect Susceptibility to Inflammatory Bowel Disease in Koreans.
    Article Snippet: .. M AN US CR IP T AC CE PT ED 12 IBD CD UC Control IBD CD UC Control IBD CD UC Control No. of samples 1,505 922 583 4,041 1,989 993 996 3,491 3,494 1,915 1,579 7,532 Male (%) 976 (64.9) 651 (70.6) 325 (55.7) 1,602 (39.6) 1,275 (64.1) 723 (72.8) 552 (55.4) 1,771 (50.7) 2,251 (64.4) 1,374 (71.7) 877 (55.5) 3,373 (44.8) Mean age at sampling (yr) 31.1 ± 13.6 25.5 ± 9.1 40.1 ± 14.7 NA 34.9 ± 13.6 28.5 ± 9.4 41.3 ± 14.2 NA 33.3 ± 13.7 27.0 ± 9.4 40.8 ± 14.4 NA Mean age at diagnosis (yr) 27.6 ± 12.6 22.3 ± 8.2 36.0 ± 13.8 31.1 ± 12.8 25.4 ± 8.7 36.8 ± 13.7 29.6 ± 12.9 23.9 ± 8.6 36.5 ± 13.7 Age group at diagnosis (%) ≤ 16 302 (20.1) 249 (27.0) 53 (9.1) NA 114 (5.7) 80 (8.1) 34 (3.4) NA 416 (11.9) 329 (17.2) 87 (5.5) NA 17∼40 917 (60.9) 634 (68.8) 283 (48.5) NA 1,419 (71.3) 841 (84.7) 578 (58.0) NA 2,336 (66.9) 1,475 (77.0) 861 (54.5) NA ≥ 40 286 (19.0) 39 (4.2) 247 (42.4) NA 456 (22.9) 72 (7.3) 384 (38.6) NA 742 (21.2) 111 (5.8) 631 (40.0) NA Location, no. (%) Ileum 161 (19.4) 228 (23.0) 389 (21.4) Colon 45 (5.4) 36 (3.6) 81 (4.5) Ileocolon 623 (75.2) 726 (73.3) 1,349 (74.2) NA 93 3 96 Extent, no. (%) Proctitis 160 (29.4) 260 (26.3) 420 (27.4) Left-sided colitis 176 (32.4) 321 (32.5) 497 (32.4) Extensive colitis 208 (38.2) 407 (41.2) 615 (40.1) NA 39 8 47 Behavior, no. (%) Inflammatory 325 (39.2) 453 (45.6) 778 (42.7) Stricturing 164 (19.8) 186 (18.7) 350 (19.2) Penetrating 341 (41.1) 354 (35.6) 695 (38.1) NA 92 92 Perianal fistula, no. (%) No 329 (39.6) 456 (45.9) 785 (43.1) Yes 501 (60.4) 537 (54.1) 1,038 (56.9) NA 92 92 GWAS set 1 Illumina chip OmniExpress12v1 Omni1-Quad No. of samples 915 532 383 745 GWAS set 2 Illumina chip HumanOmniExpressExome8v1 Omni1-Quad No. of samples 590 390 200 3,296 Replication set Genotyping technology Sequenom iPLEX, TaqMan SNP genotyping assay No. of samples 1,989 cases 3,491 controls* Supplementary Table 1. ..

    Sampling:

    Article Title: Identification of Loci at 1q21 and 16q23 That Affect Susceptibility to Inflammatory Bowel Disease in Koreans.
    Article Snippet: .. M AN US CR IP T AC CE PT ED 12 IBD CD UC Control IBD CD UC Control IBD CD UC Control No. of samples 1,505 922 583 4,041 1,989 993 996 3,491 3,494 1,915 1,579 7,532 Male (%) 976 (64.9) 651 (70.6) 325 (55.7) 1,602 (39.6) 1,275 (64.1) 723 (72.8) 552 (55.4) 1,771 (50.7) 2,251 (64.4) 1,374 (71.7) 877 (55.5) 3,373 (44.8) Mean age at sampling (yr) 31.1 ± 13.6 25.5 ± 9.1 40.1 ± 14.7 NA 34.9 ± 13.6 28.5 ± 9.4 41.3 ± 14.2 NA 33.3 ± 13.7 27.0 ± 9.4 40.8 ± 14.4 NA Mean age at diagnosis (yr) 27.6 ± 12.6 22.3 ± 8.2 36.0 ± 13.8 31.1 ± 12.8 25.4 ± 8.7 36.8 ± 13.7 29.6 ± 12.9 23.9 ± 8.6 36.5 ± 13.7 Age group at diagnosis (%) ≤ 16 302 (20.1) 249 (27.0) 53 (9.1) NA 114 (5.7) 80 (8.1) 34 (3.4) NA 416 (11.9) 329 (17.2) 87 (5.5) NA 17∼40 917 (60.9) 634 (68.8) 283 (48.5) NA 1,419 (71.3) 841 (84.7) 578 (58.0) NA 2,336 (66.9) 1,475 (77.0) 861 (54.5) NA ≥ 40 286 (19.0) 39 (4.2) 247 (42.4) NA 456 (22.9) 72 (7.3) 384 (38.6) NA 742 (21.2) 111 (5.8) 631 (40.0) NA Location, no. (%) Ileum 161 (19.4) 228 (23.0) 389 (21.4) Colon 45 (5.4) 36 (3.6) 81 (4.5) Ileocolon 623 (75.2) 726 (73.3) 1,349 (74.2) NA 93 3 96 Extent, no. (%) Proctitis 160 (29.4) 260 (26.3) 420 (27.4) Left-sided colitis 176 (32.4) 321 (32.5) 497 (32.4) Extensive colitis 208 (38.2) 407 (41.2) 615 (40.1) NA 39 8 47 Behavior, no. (%) Inflammatory 325 (39.2) 453 (45.6) 778 (42.7) Stricturing 164 (19.8) 186 (18.7) 350 (19.2) Penetrating 341 (41.1) 354 (35.6) 695 (38.1) NA 92 92 Perianal fistula, no. (%) No 329 (39.6) 456 (45.9) 785 (43.1) Yes 501 (60.4) 537 (54.1) 1,038 (56.9) NA 92 92 GWAS set 1 Illumina chip OmniExpress12v1 Omni1-Quad No. of samples 915 532 383 745 GWAS set 2 Illumina chip HumanOmniExpressExome8v1 Omni1-Quad No. of samples 590 390 200 3,296 Replication set Genotyping technology Sequenom iPLEX, TaqMan SNP genotyping assay No. of samples 1,989 cases 3,491 controls* Supplementary Table 1. ..

    Biomarker Discovery:

    Article Title: Identification of Loci at 1q21 and 16q23 That Affect Susceptibility to Inflammatory Bowel Disease in Koreans.
    Article Snippet: .. M AN US CR IP T AC CE PT ED 12 IBD CD UC Control IBD CD UC Control IBD CD UC Control No. of samples 1,505 922 583 4,041 1,989 993 996 3,491 3,494 1,915 1,579 7,532 Male (%) 976 (64.9) 651 (70.6) 325 (55.7) 1,602 (39.6) 1,275 (64.1) 723 (72.8) 552 (55.4) 1,771 (50.7) 2,251 (64.4) 1,374 (71.7) 877 (55.5) 3,373 (44.8) Mean age at sampling (yr) 31.1 ± 13.6 25.5 ± 9.1 40.1 ± 14.7 NA 34.9 ± 13.6 28.5 ± 9.4 41.3 ± 14.2 NA 33.3 ± 13.7 27.0 ± 9.4 40.8 ± 14.4 NA Mean age at diagnosis (yr) 27.6 ± 12.6 22.3 ± 8.2 36.0 ± 13.8 31.1 ± 12.8 25.4 ± 8.7 36.8 ± 13.7 29.6 ± 12.9 23.9 ± 8.6 36.5 ± 13.7 Age group at diagnosis (%) ≤ 16 302 (20.1) 249 (27.0) 53 (9.1) NA 114 (5.7) 80 (8.1) 34 (3.4) NA 416 (11.9) 329 (17.2) 87 (5.5) NA 17∼40 917 (60.9) 634 (68.8) 283 (48.5) NA 1,419 (71.3) 841 (84.7) 578 (58.0) NA 2,336 (66.9) 1,475 (77.0) 861 (54.5) NA ≥ 40 286 (19.0) 39 (4.2) 247 (42.4) NA 456 (22.9) 72 (7.3) 384 (38.6) NA 742 (21.2) 111 (5.8) 631 (40.0) NA Location, no. (%) Ileum 161 (19.4) 228 (23.0) 389 (21.4) Colon 45 (5.4) 36 (3.6) 81 (4.5) Ileocolon 623 (75.2) 726 (73.3) 1,349 (74.2) NA 93 3 96 Extent, no. (%) Proctitis 160 (29.4) 260 (26.3) 420 (27.4) Left-sided colitis 176 (32.4) 321 (32.5) 497 (32.4) Extensive colitis 208 (38.2) 407 (41.2) 615 (40.1) NA 39 8 47 Behavior, no. (%) Inflammatory 325 (39.2) 453 (45.6) 778 (42.7) Stricturing 164 (19.8) 186 (18.7) 350 (19.2) Penetrating 341 (41.1) 354 (35.6) 695 (38.1) NA 92 92 Perianal fistula, no. (%) No 329 (39.6) 456 (45.9) 785 (43.1) Yes 501 (60.4) 537 (54.1) 1,038 (56.9) NA 92 92 GWAS set 1 Illumina chip OmniExpress12v1 Omni1-Quad No. of samples 915 532 383 745 GWAS set 2 Illumina chip HumanOmniExpressExome8v1 Omni1-Quad No. of samples 590 390 200 3,296 Replication set Genotyping technology Sequenom iPLEX, TaqMan SNP genotyping assay No. of samples 1,989 cases 3,491 controls* Supplementary Table 1. ..

    GWAS:

    Article Title: Identification of Loci at 1q21 and 16q23 That Affect Susceptibility to Inflammatory Bowel Disease in Koreans.
    Article Snippet: .. M AN US CR IP T AC CE PT ED 12 IBD CD UC Control IBD CD UC Control IBD CD UC Control No. of samples 1,505 922 583 4,041 1,989 993 996 3,491 3,494 1,915 1,579 7,532 Male (%) 976 (64.9) 651 (70.6) 325 (55.7) 1,602 (39.6) 1,275 (64.1) 723 (72.8) 552 (55.4) 1,771 (50.7) 2,251 (64.4) 1,374 (71.7) 877 (55.5) 3,373 (44.8) Mean age at sampling (yr) 31.1 ± 13.6 25.5 ± 9.1 40.1 ± 14.7 NA 34.9 ± 13.6 28.5 ± 9.4 41.3 ± 14.2 NA 33.3 ± 13.7 27.0 ± 9.4 40.8 ± 14.4 NA Mean age at diagnosis (yr) 27.6 ± 12.6 22.3 ± 8.2 36.0 ± 13.8 31.1 ± 12.8 25.4 ± 8.7 36.8 ± 13.7 29.6 ± 12.9 23.9 ± 8.6 36.5 ± 13.7 Age group at diagnosis (%) ≤ 16 302 (20.1) 249 (27.0) 53 (9.1) NA 114 (5.7) 80 (8.1) 34 (3.4) NA 416 (11.9) 329 (17.2) 87 (5.5) NA 17∼40 917 (60.9) 634 (68.8) 283 (48.5) NA 1,419 (71.3) 841 (84.7) 578 (58.0) NA 2,336 (66.9) 1,475 (77.0) 861 (54.5) NA ≥ 40 286 (19.0) 39 (4.2) 247 (42.4) NA 456 (22.9) 72 (7.3) 384 (38.6) NA 742 (21.2) 111 (5.8) 631 (40.0) NA Location, no. (%) Ileum 161 (19.4) 228 (23.0) 389 (21.4) Colon 45 (5.4) 36 (3.6) 81 (4.5) Ileocolon 623 (75.2) 726 (73.3) 1,349 (74.2) NA 93 3 96 Extent, no. (%) Proctitis 160 (29.4) 260 (26.3) 420 (27.4) Left-sided colitis 176 (32.4) 321 (32.5) 497 (32.4) Extensive colitis 208 (38.2) 407 (41.2) 615 (40.1) NA 39 8 47 Behavior, no. (%) Inflammatory 325 (39.2) 453 (45.6) 778 (42.7) Stricturing 164 (19.8) 186 (18.7) 350 (19.2) Penetrating 341 (41.1) 354 (35.6) 695 (38.1) NA 92 92 Perianal fistula, no. (%) No 329 (39.6) 456 (45.9) 785 (43.1) Yes 501 (60.4) 537 (54.1) 1,038 (56.9) NA 92 92 GWAS set 1 Illumina chip OmniExpress12v1 Omni1-Quad No. of samples 915 532 383 745 GWAS set 2 Illumina chip HumanOmniExpressExome8v1 Omni1-Quad No. of samples 590 390 200 3,296 Replication set Genotyping technology Sequenom iPLEX, TaqMan SNP genotyping assay No. of samples 1,989 cases 3,491 controls* Supplementary Table 1. ..

    TaqMan SNP Genotyping Assay:

    Article Title: Identification of Loci at 1q21 and 16q23 That Affect Susceptibility to Inflammatory Bowel Disease in Koreans.
    Article Snippet: .. M AN US CR IP T AC CE PT ED 12 IBD CD UC Control IBD CD UC Control IBD CD UC Control No. of samples 1,505 922 583 4,041 1,989 993 996 3,491 3,494 1,915 1,579 7,532 Male (%) 976 (64.9) 651 (70.6) 325 (55.7) 1,602 (39.6) 1,275 (64.1) 723 (72.8) 552 (55.4) 1,771 (50.7) 2,251 (64.4) 1,374 (71.7) 877 (55.5) 3,373 (44.8) Mean age at sampling (yr) 31.1 ± 13.6 25.5 ± 9.1 40.1 ± 14.7 NA 34.9 ± 13.6 28.5 ± 9.4 41.3 ± 14.2 NA 33.3 ± 13.7 27.0 ± 9.4 40.8 ± 14.4 NA Mean age at diagnosis (yr) 27.6 ± 12.6 22.3 ± 8.2 36.0 ± 13.8 31.1 ± 12.8 25.4 ± 8.7 36.8 ± 13.7 29.6 ± 12.9 23.9 ± 8.6 36.5 ± 13.7 Age group at diagnosis (%) ≤ 16 302 (20.1) 249 (27.0) 53 (9.1) NA 114 (5.7) 80 (8.1) 34 (3.4) NA 416 (11.9) 329 (17.2) 87 (5.5) NA 17∼40 917 (60.9) 634 (68.8) 283 (48.5) NA 1,419 (71.3) 841 (84.7) 578 (58.0) NA 2,336 (66.9) 1,475 (77.0) 861 (54.5) NA ≥ 40 286 (19.0) 39 (4.2) 247 (42.4) NA 456 (22.9) 72 (7.3) 384 (38.6) NA 742 (21.2) 111 (5.8) 631 (40.0) NA Location, no. (%) Ileum 161 (19.4) 228 (23.0) 389 (21.4) Colon 45 (5.4) 36 (3.6) 81 (4.5) Ileocolon 623 (75.2) 726 (73.3) 1,349 (74.2) NA 93 3 96 Extent, no. (%) Proctitis 160 (29.4) 260 (26.3) 420 (27.4) Left-sided colitis 176 (32.4) 321 (32.5) 497 (32.4) Extensive colitis 208 (38.2) 407 (41.2) 615 (40.1) NA 39 8 47 Behavior, no. (%) Inflammatory 325 (39.2) 453 (45.6) 778 (42.7) Stricturing 164 (19.8) 186 (18.7) 350 (19.2) Penetrating 341 (41.1) 354 (35.6) 695 (38.1) NA 92 92 Perianal fistula, no. (%) No 329 (39.6) 456 (45.9) 785 (43.1) Yes 501 (60.4) 537 (54.1) 1,038 (56.9) NA 92 92 GWAS set 1 Illumina chip OmniExpress12v1 Omni1-Quad No. of samples 915 532 383 745 GWAS set 2 Illumina chip HumanOmniExpressExome8v1 Omni1-Quad No. of samples 590 390 200 3,296 Replication set Genotyping technology Sequenom iPLEX, TaqMan SNP genotyping assay No. of samples 1,989 cases 3,491 controls* Supplementary Table 1. ..



    Similar Products

    86
    Sequenom sequenom massarray snp genotyping
    Sequenom Massarray Snp Genotyping, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/massarray+platform/pmc12767390-54-4-4
    Average 86 stars, based on 1 article reviews
    sequenom massarray snp genotyping - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Sequenom sequenom massarray snp genotyping platform
    Sequenom Massarray Snp Genotyping Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/massarray+platform/pmc12319242-115-39-39
    Average 86 stars, based on 1 article reviews
    sequenom massarray snp genotyping platform - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    90
    Sequenom snp genotyping by sequenom massarray maldi-tof mass spectrometry
    Snp Genotyping By Sequenom Massarray Maldi Tof Mass Spectrometry, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/mass+spectrometry+snp+genotyping+system/bio_rxiv__2025__04__27__649857-385-4-7
    Average 90 stars, based on 1 article reviews
    snp genotyping by sequenom massarray maldi-tof mass spectrometry - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Sequenom taqman® snp genotyping sequenom® massarray® nb (structure) 10 populations
    Taqman® Snp Genotyping Sequenom® Massarray® Nb (Structure) 10 Populations, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/taqman+snp+genotyping+assay/pm39990695-65-69-77
    Average 90 stars, based on 1 article reviews
    taqman® snp genotyping sequenom® massarray® nb (structure) 10 populations - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Sequenom taqman® snp genotyping sequenom® massarray
    Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used <t> genotyping </t> technology and prediction model, inferred populations, and related articles.
    Taqman® Snp Genotyping Sequenom® Massarray, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/taqman+snp+genotyping+assay/pmc11843099-32-6-9
    Average 90 stars, based on 1 article reviews
    taqman® snp genotyping sequenom® massarray - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Sequenom snp genotyping sequenom massarray iplex platform
    Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used <t> genotyping </t> technology and prediction model, inferred populations, and related articles.
    Snp Genotyping Sequenom Massarray Iplex Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/sequenom+massarray/pmc11545541-177-2-6
    Average 90 stars, based on 1 article reviews
    snp genotyping sequenom massarray iplex platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Sequenom snp genotyping using the sequenom massarray iplex platform
    Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used <t> genotyping </t> technology and prediction model, inferred populations, and related articles.
    Snp Genotyping Using The Sequenom Massarray Iplex Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/sequenom+massarray/10__1093_slash_icesjms_slash_fsae055-493-11-17
    Average 90 stars, based on 1 article reviews
    snp genotyping using the sequenom massarray iplex platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Sequenom snp genotyping using sequenom massarray 7k platform
    Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used <t> genotyping </t> technology and prediction model, inferred populations, and related articles.
    Snp Genotyping Using Sequenom Massarray 7k Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sequenom+massarray+snp+genotyping/sequenom+massarray/10__1007_slash_s10592___023___01556___9-191-4-10
    Average 90 stars, based on 1 article reviews
    snp genotyping using sequenom massarray 7k platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used  genotyping  technology and prediction model, inferred populations, and related articles.

    Journal: Forensic Sciences Research

    Article Title: Forensic DNA phenotyping: a review on SNP panels, genotyping techniques, and prediction models

    doi: 10.1093/fsr/owae013

    Figure Lengend Snippet: Non-commercial bio-geographical ancestry (BGA) panels proposed in the literature, including their reference article, number and ancestry informative SNPs (AISNPs) type, first used genotyping technology and prediction model, inferred populations, and related articles.

    Article Snippet: [ ] , 74 aSNPs , TaqMan® SNP genotyping Sequenom® MassARRAY® , NB (STRUCTURE) , 10 populations (sub-Saharan AFR and NAF, EUR, SWAS, NAS, SAS, EAS, SEAS, OCE, NAM) , [ ] .

    Techniques: Sequencing, Multiplex Assay

    Commercial and non-commercial externally visible characteristics (EVC) panels proposed in the literature, including their reference article, number of phenotypic-informative SNPs (PISNPs), first used  genotyping  technology and prediction model, inferred traits, and related articles

    Journal: Forensic Sciences Research

    Article Title: Forensic DNA phenotyping: a review on SNP panels, genotyping techniques, and prediction models

    doi: 10.1093/fsr/owae013

    Figure Lengend Snippet: Commercial and non-commercial externally visible characteristics (EVC) panels proposed in the literature, including their reference article, number of phenotypic-informative SNPs (PISNPs), first used genotyping technology and prediction model, inferred traits, and related articles

    Article Snippet: [ ] , 74 aSNPs , TaqMan® SNP genotyping Sequenom® MassARRAY® , NB (STRUCTURE) , 10 populations (sub-Saharan AFR and NAF, EUR, SWAS, NAS, SAS, EAS, SEAS, OCE, NAM) , [ ] .

    Techniques: Sequencing, Microarray